Toward in vivo-relevant hERG safety assessment and mitigation strategies based on relationships between non-equilibrium blocker binding, three-dimensional channel-blocker interactions, dynamic occupancy, dynamic exposure, and cellular arrhythmia
This article has been Reviewed by the following groups
Listed in
- Evaluated articles (preLights)
Abstract
No abstract available
Article activity feed
-
-
Excerpt
Mitigating the “harm” in “pharm”: strategies to predict, identify, and mitigate drug adverse reactions
-
